NXTC (STOCKS)
NextCure, Inc. Common Stock
$2.010000
-0.065000 (-3.13%)
Prev close: $2.075000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Michael S. Richman
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $7.19M
- Employees
- 43
- P/E (TTM)
- -0.10
- P/B (TTM)
- 0.27
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
3
Strong Buy
5
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$-1.87 | $-2.15 | +0.2751 | +12.82% |
|
Dec 2025 (Q4)
|
$-0.81 | $-2.47 | +1.6550 | +67.14% |
|
Sep 2025 (Q3)
|
$-3.22 | $-4.06 | +0.8430 | +20.75% |
|
Jun 2025 (Q2)
|
$-11.29 | $-4.71 | -6.5827 | -139.84% |
Financial Statements
| Revenues | $0.00 |
| Operating Expenses | $56.10M |
| Research and Development | $43.86M |
| Other Operating Expenses | $12.24M |
| Operating Income/Loss | -$56.10M |
| Income/Loss From Continuing Operations After Tax | -$54.66M |
| Income/Loss From Continuing Operations Before Tax | -$54.66M |
| Income Tax Expense/Benefit | $0.00 |
| Net Income/Loss | -$54.66M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$54.66M |
| Net Income/Loss Available To Common Stockholders, Basic | -$54.66M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$17.19 |
| Diluted Earnings Per Share | -$17.19 |
| Basic Average Shares | 10,669,708 |
| Diluted Average Shares | 10,669,708 |
| Assets | $37.98M |
| Current Assets | $31.74M |
| Noncurrent Assets | $6.24M |
| Fixed Assets | $2.99M |
| Other Non-current Assets | $3.25M |
| Liabilities | $11.26M |
| Current Liabilities | $6.89M |
| Accounts Payable | $3.07M |
| Other Current Liabilities | $3.82M |
| Noncurrent Liabilities | $4.37M |
| Equity | $26.72M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $26.72M |
| Liabilities And Equity | $37.98M |
| Net Cash Flow From Operating Activities | -$49.98M |
| Net Cash Flow From Operating Activities, Continuing | -$49.98M |
| Net Cash Flow From Investing Activities | $19.76M |
| Net Cash Flow From Investing Activities, Continuing | $19.76M |
| Net Cash Flow From Financing Activities | $17.66M |
| Net Cash Flow From Financing Activities, Continuing | $17.66M |
| Net Cash Flow | -$12.56M |
| Net Cash Flow, Continuing | -$12.56M |
| Comprehensive Income/Loss | -$54.66M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$54.67M |
| Other Comprehensive Income/Loss | -$8.62M |